Skip to search formSkip to main contentSkip to account menu

Cylert

Known as: Abbott Brand of Pemoline 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
  • T. Wilens
  • The Journal of clinical psychiatry
  • 2004
  • Corpus ID: 1752149
Attention-deficit/hyperactivity disorder (ADHD) is a risk factor for substance abuse in adults. Additional psychiatric… 
Review
2002
Review
2002
Although first identified in children in the 19th century, attention-deficit/hyperactivity disorder (ADHD) in adults was not… 
2002
2002
OBJECTIVE To assess compliance with product labeling recommendations to use pemoline as second-line therapy for attention-deficit… 
Highly Cited
2001
Highly Cited
2001
This article examines the medical discourse that formed the foundations of what mental health professionals today call Attention… 
Review
2001
Review
2001
  • C. Poulin
  • CMAJ : Canadian Medical Association journal…
  • 2001
  • Corpus ID: 5561592
BACKGROUND The past decade has seen a generalized upward trend in the prevalence of adolescent use of substances, including… 
Review
2001
Review
2001
BACKGROUND Fatigue is a commonly encountered symptom of human immunodeficiency virus (HIV) disease, associated with significant… 
Highly Cited
1998
Highly Cited
1998
This investigation examined the efficacy of psychostimulant therapy in alleviating neurobehavioral dysfunction attendant to… 
1990
1990
  • D. PrattR. Dubois
  • Journal of pediatric gastroenterology and…
  • 1990
  • Corpus ID: 45982605
Pemoline (Cylert) is an agent used to treat attention deficit disorders and other behavioral syndromes. There have, however, been…